News cbdMD, Inc.

Equities

YCBD

US12482W3097

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:00 2025-04-24 pm EDT			5-day change	1st Jan Change
0.2550 ^USD	+6.29%		+10.87%	-32.00%

Apr. 11	CbdMD, Inc. Elects Directors	CI
Feb. 13	CbdMD, Inc., Q1 2025 Earnings Call, Feb 13, 2025

Herbal Oasis Wins National Recognition at the 2025 High Spirits Awards	Apr. 24	NE
CbdMD, Inc. Announces Automatic Conversion Date of Series A Preferred Stock and One for Eight Reverse Split of its Common Stock Immediately Following the Automatic Conversion	Apr. 21	NE
CbdMD, Inc. Elects Directors	Apr. 11	CI
CbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting	Apr. 10	NE
Herbal Oasis Announces Distribution Agreement to Launch Statewide in Alabama and Select Florida Panhandle Markets	Apr. 08	NE
CbdMD Achieves Key Milestone in UK Novel Food Regulatory Approval	Apr. 07	NE
CbdMD, Inc., Q1 2025 Earnings Call, Feb 13, 2025	Feb. 13
CbdMD Generates $5.1 Million in Revenue, Positive Earnings	Feb. 13	NE
CbdMD, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2024	Feb. 13	CI
CbdMD, Inc. to Host Conference Call to Discuss December 31, 2024 First Quarter of Fiscal Year 2025 Results	Feb. 07	NE
CbdMD Announces It Has Fully Satisfied Its Notes	Jan. 15	NE
CbdMD Announces Additional Conversions of Its Convertible Notes	Jan. 08	NE
CbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standard	Jan. 06	AQ
CbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standard	Jan. 03	NE
CbdMD : Announces Company’s CEO joins the Board of Directors Form 8 K	Dec. 23	PU
CbdMD, Inc. Appoints T. Ronan Kennedy to Its Board of Directors	Dec. 23	CI
CbdMD Announces Company's CEO Joins the Board of Directors	Dec. 23	NE
CbdMD, Inc., Q4 2024 Earnings Call, Dec 18, 2024	Dec. 18
CbdMD Generates $19.1 Million in Year Over Year Reduction in Net Loss Improvement	Dec. 18	NE
CbdMD : Annual Report for Fiscal Year Ending 09 30, 2024 (Form 10 K)	Dec. 18	PU
CbdMD, Inc. Reports Earnings Results for the Full Year Ended September 30, 2024	Dec. 18	CI
CbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results	Dec. 18	NE
CbdMD, Inc. Auditor Raises 'Going Concern' Doubt	Dec. 17	CI
CbdMD, Inc. Reschedules Earnings Release and Conference Call	Dec. 17	NE
CbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results	Dec. 12	NE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News cbdMD, Inc.

Equities

YCBD

US12482W3097

Pharmaceuticals

Filters